Prophylactic Antimalarial Activity of DB289 in Volunteers
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the prophylactic activity of orally administered DB289 against Plasmodium
falciparum in non-immune healthy volunteers who are challenged by the bite of five P.
falciparum-infected Anopheles stephensi mosquitoes